Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22,672,988
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
20,084,131
-
Shares change
-
+604,078
-
Total reported value, excl. options
-
$1,139,986,402
-
Value change
-
+$34,733,932
-
Put/Call ratio
-
3.9%
-
Number of buys
-
115
-
Number of sells
-
89
-
Price
-
$56.76
Institutional Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q4 2023
As of 31 Dec 2023 LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) had 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,084,131 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, Ranger Investment Management, L.P., GENEVA CAPITAL MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, CONGRESS ASSET MANAGEMENT CO /MA, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 226 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.